Titles
- Digital health technologies for remote data acquisition in clinical investigations: guidance for industry, investigators, and other stakeholders1
- Direct-to-consumer prescription drug advertisements: presentation of the major statement in a clear, conspicuous, and neutral manner in advertisements in television and radio format final rule : questions and answers : guidance for industry1
- Disaggregating race and ethnicity data: findings from community focus groups1
- Disparities in Minnesota’s COVID-19 vaccination rates1
- Do No Harm guide. Collecting, analyzing, and reporting gender and sexual orientation data1
- Does schooling improve cognitive abilities at older ages?: causal evidence from nonparametric bounds1
- Does temporary disability insurance reduce older workers’ reliance on Social Security disability insurance?1
- Driving better health outcomes through integrated care systems: the role of district councils1
- During the initial COVID-19 response, HHS personnel who interacted with potentially infected passengers had limited protections1
- Dying well at home: commissioning quality end-of-life care1
- Early challenges highlight areas for improvement in COVID-19 vaccination programs1
- Early lessons from CalAIM initiatives to address behavioral health needs1
- Effect of nudges to clinicians, patients, or both to increase statin prescribing: a cluster randomized clinical trial1
- Eliminating access to no-cost preventive health services could affect more than 12 million adults ages 50 to 641
- Emergency care1
- Emerging practices for supporting LGBTQI+ young people across human services programs1
- Enforcement policy for certain supplements for Approved Premarket Approval (PMA) or Humanitarian Device Exemption (HDE) submissions: guidance for industry and Food and Drug Administration staff1
- Enforcement policy for clinical electronic thermometers: guidance for industry and Food and Drug Administration staff1
- Enforcement policy for non-invasive remote monitoring devices used to support patient monitoring: guidance for industry and Food and Drug Administration staff1
- Enhanced drug distribution security at the package level under the Drug Supply Chain Security Act: guidance for industry1